Page last updated: 2024-08-26

bosentan anhydrous and Carcinoid Heart Disease

bosentan anhydrous has been researched along with Carcinoid Heart Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbetakis, NG; Bischiniotis, TS; Ilonidis, GC; Lafaras, CT; Mandala, EM; Paraskevopoulos, PP; Platogiannis, DN; Saratzis, AN	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Carcinoid Heart Disease

Article	Year
Evaluation of treatment with bosentan in patients with carcinoid heart disease: single center study. Onkologie, 2010, Volume: 33, Issue:6 Topics: Aged; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Bosentan; Carcinoid Heart Disease; Combined Modality Therapy; Echocardiography, Doppler; Endothelin Receptor Antagonists; Exercise Test; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Natriuretic Peptide, Brain; Ovarian Neoplasms; Peptide Fragments; Sulfonamides	2010

Article

Year

Evaluation of treatment with bosentan in patients with carcinoid heart disease: single center study.

Onkologie, 2010, Volume: 33, Issue:6

Topics: Aged; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Bosentan; Carcinoid Heart Disease; Combined Modality Therapy; Echocardiography, Doppler; Endothelin Receptor Antagonists; Exercise Test; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Natriuretic Peptide, Brain; Ovarian Neoplasms; Peptide Fragments; Sulfonamides

2010